Zebra Announces Regulatory Approval of its Deep Learning Imaging Analytics Engine

Zebra Medical VisionZebra Medical Vision, the leading machine learning imaging analytics company, announces that the company has been granted the CE approval and subsequent release of its Deep Learning Analytics Engine in Europe, as well as regulatory clearance and product release in Australia and New Zealand. The company's Analytics Engine provides automated analysis of imaging data, helping radiologists provide faster, more accurate and comprehensive reports. The Engine can be integrated into PACS, RIS, Reporting and EMR systems, providing a seamless flow for physicians.

AI in healthcare has been gaining significant support and adoption over the past 12 months. In a recent Research and Markets report, it was estimated that Artificial Intelligence in healthcare will witness a CAGR of 62.2% between 2016-2022. The Zebra-Med Engine currently analyzes CT data for signs of:

  • Fatty Liver
  • Excess coronary calcium
  • Emphysema
  • Low bone density
  • Vertebral compression fractures

In addition, more than a dozen new algorithms that detect life threatening diseases will be released in the coming months. Zebra-Med's engine can be deployed in both cloud and on-premise configurations, and its insights help radiologists provide more comprehensive, consistent reports. The company's unique platform allows healthcare organizations to discover chronic diseases earlier, giving those organizations the opportunity to establish preventative care programs, improving care while reducing the overall patient treatment costs.

"Machine Learning will change the way Radiology is practiced in the coming years," says Prof. Gabriel Krestin, Chairman of the Department of Radiology and Nuclear Medicine at Erasmus MC, University Medical Centre Rotterdam, the Netherlands. "I believe it will make radiologists more productive, and I also believe that new use cases and value propositions will emerge as the technology is implemented widely. It is a very exciting time for radiology."

"These recent regulatory approvals allow us to continue driving adoption of our Analytics Engine globally, where we see significant interest in countries that have a problematic ratio of radiologists per capita. Providing tools that assist them in delivering better care is critical and is the driving force behind our mission," says Elad Benjamin, Co-Founder and CEO at Zebra-Med. "We have already begun working with luminary university hospitals in Europe, and will continue to expand our footprint across the region."

About Zebra Medical Vision
A FastCompany Top 5 Machine Learning startup, Zebra Medical Vision uses machine and deep learning to create and provide next generation products and services to the healthcare industry. Its Imaging Analytics Platform allows healthcare institutions to identify patients at risk of disease, and offer improved, preventative treatment pathways to better patient care. Headquartered in Kibbutz Shefayim, Israel, the company was founded in 2014 by co-founders Eyal Toledano, Eyal Gura, and Elad Benjamin, and funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd and Dolby Ventures. For more information visit www.zebra-med.com.

Most Popular Now

Designing Soft Robots: Ethics-Based Guid…

Soft-bodied robots offer the possibility for social engagement, and novel tactile human-robot interactions that require careful consideration of the potential for misplaced emotional attachments and personally and socially destructive behavior...

Breathable, Wearable Electronics on Skin…

A hypoallergenic electronic sensor can be worn on the skin continuously for a week without discomfort, and is so light and thin that users forget they even have it on...

Google Searches can be Used to Track Den…

An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational...

IMI Launches EUR 130 Million Calls for P…

The Innovative Medicines Initiative (IMI) is launching two new Calls for proposals with topics on Alzheimer's disease, big data, vaccines, autoimmune disease, the blood-brain barrier, drug development, and the exploitation...

The Danish Reference Genome

After close to 5 years of work, the GenomeDenmark consortium has now finalized the efforts to establish a Danish Reference genome. The result is a reference of unrivalled quality and...

NHS Fife Connects Hospitals Following Su…

Ten hospitals across Fife are using real-time information to deliver better co-ordinated care for thousands of patients, following the successful go-live of InterSystems TrakCare®. Frontline staff in all of NHS...

eHealth Innovation Days 2017

7 - 8 September 2017, Flensburg, Germany. The 2nd eHealth Innovation Days will gather the different professionals and stakeholders concerned with eHealth: developers, healthcare professionals, researchers, policy makers, citizens as well...

Philips and Italian Fatebenefratelli Hos…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the historic San Giovanni Calibita Fatebenefratelli Hospital in Rome today announced a long-term strategic partnership to introduce...

Philips to Strengthen its Ultrasound Bus…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has signed an agreement to acquire TomTec Imaging Systems GmbH (TOMTEC), a leading provider of intelligent image analysis...